IPRIPR2017-00028Final Written Decision
Laboratoire Francais du Fractionnement et des Biotechnologies S.A.v.Novo Nordisk Healthcare AG
IPR challenge of US 9102762.
Type
IPR
Filed
Oct 7, 2016
Instituted
Apr 11, 2017
Decided
Apr 13, 2022
Patent
Application
13349980
Inventor
Jesper Christensen et al
Granted
Aug 11, 2015
01
Timeline
3 milestones
2016-10-07Petition filed
2017-04-11Institution
2022-04-13Terminated
02
Parties & counsel
Petitioner
Laboratoire Francais du Fractionnement et des Biotechnologies S.A.
Counsel
Houston, Michael R.et al
Patent Owner
Novo Nordisk Healthcare AG
Counsel
Oelke, Jeffrey
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →